
Bio-Techne Corporation
TECH
•Stock Analysis$61.86
+0.00 (+0.00%)• Live
Bio-Techne Corporation Analysis Dashboard - Stock Analysis and Financial Metrics
Historical Prices
for Bio-Techne Corporation
Key Financial Metrics
for Bio-Techne Corporation
P/E Ratio
61.60
Revenue Growth
+1.97%
EPS Growth
-40.88%
Market Cap
$8.08B
Dividend Yield
+0.62%
Debt/Equity
0.21
ROIC
+6.66%
FCF Yield
+2.73%
View additional metrics
Valuation
P/B Ratio4.02
EV/Sales6.92
Financial Health
Current Ratio3.71
Return on Assets+10.69%
Analyst Recommendations
for Bio-Techne Corporation
23 analysts
Consensus: Buy
About
for Bio-Techne Corporation
Company Details
for Bio-Techne Corporation
Sector
Healthcare
Industry
Biotechnology
CEO
Kim Kelderman
Employees
3,100
Market Cap
9.74B
Exchange
NASDAQ Global Select
IPO Date
February 9, 1989
Website
www.bio-techne.comCIK
0000842023
ISIN
US09073M1045
CUSIP
09073M104
Country
US
Balance Sheet
for Bio-Techne Corporation
Cash Flow Statement
for Bio-Techne Corporation
Income Statement
for Bio-Techne Corporation

News
No news available at the moment.